Fourteen option delistings on September 24th
Upcoming Delistings: A list of companies and ETFs, including Alimera Sciences Inc. and Rite Aid Corporation, will be delisted effective September 24th.
Affected Companies: Other notable delisted entities include ASSETMARK FINANCIAL HOLDINGS INC., Ebix, Inc., and Taro Pharmaceutical Industries Ltd.
Trade with 70% Backtested Accuracy
Analyst Views on GRIN
No data
About GRIN
About the author
Grown Rogue International's Expansion and Financial Outlook
- Revenue Growth Expectations: Grown Rogue International anticipates double-digit revenue growth in Q1 2026 compared to Q1 2025, indicating strong momentum in market recovery and boosting investor confidence.
- Production Capacity Expansion: The company plans to increase its flowering canopy from 37,000 square feet to 58,000 square feet in 2026, expecting a 50% boost in production capacity to meet demand in New Jersey, Illinois, and Minnesota, thereby solidifying its market position.
- Financial Support: Successfully secured a $12 million debt facility at a sub-8% interest rate, providing financial backing for expansion projects, particularly in Minnesota and New Jersey, which mitigates financial risk.
- Team Building and Management: By attracting external talent and promoting internal leaders, the company has strengthened its capabilities in key areas such as construction, marketing, and management, enhancing its ability to navigate market challenges and drive growth, reflecting its commitment to future development.
Grown Rogue International's Expansion Plans for 2026
- Revenue Growth Expectation: Grown Rogue International anticipates double-digit revenue growth in Q1 2026 compared to Q1 2025, indicating strong momentum in market recovery and boosting investor confidence.
- Production Capacity Increase: The company currently has a flowering canopy of 37,000 square feet, with plans to add 21,000 square feet in 2026, representing a 50% increase that will significantly enhance its market supply capabilities and support future sales growth.
- Debt Financing Support: Successfully secured a $12 million debt facility at a sub-8% interest rate, providing financial backing for expansion plans in New Jersey and Minnesota while reducing financial costs.
- Market Challenge Response: Despite facing cyclical pricing pressures in Oregon and Michigan, the company maintains a low-cost, high-quality production model, expecting double-digit revenue growth in Q1 2026, demonstrating its market adaptability and resilience.
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
Corporate Developments: The cannabis industry is experiencing significant activity with major acquisitions, such as Organigram's purchase of Collective Project Limited, and financial improvements reported by companies like Canopy Growth and Grown Rogue International, indicating a dynamic market landscape.
Regulatory and Product Innovations: Legal debates continue to shape cannabis policy, highlighted by a U.S. Supreme Court ruling favoring a trucker fired for THC use, while new product launches from brands like Grön and MariMed reflect ongoing consumer market expansion in states like Illinois.
Cannabis Co. Grown Rogue Reports 7% Increase In Q3 Revenue, Focuses On New Jersey And Illinois Expansion
Financial Performance: Grown Rogue International reported a 7% increase in revenue to $7 million for Q3 2024, but experienced a decrease in gross profit and operating cash flow due to increased expenses and pricing pressures. The net loss improved to $667,240 compared to the previous year.
Expansion Plans: The company is focusing on its expansions in New Jersey and Illinois, with product launches expected in December 2024 and ongoing construction aimed at increasing production capacity by mid-2025.
Grown Rogue Secures $800K, Vireo Forfeits 4.5M Warrants In Cannabis Shakeup—What's Next For Both?
Grown Rogue and Vireo Growth Agreement Termination: Grown Rogue International has terminated its advisory agreement with Vireo Growth, resulting in Vireo forfeiting 4.5 million warrants and agreeing to pay Grown Rogue $800,000, while Grown Rogue retains 10 million warrants.
Leadership Changes at Vireo Growth: Vireo Growth appointed Amber Shimpa as CEO following the resignation of Josh Rosen, who will remain an advisor, as the company prepares for expansion into Minnesota's adult-use market next year.
Cannabis Sales In Michigan Soar To $295.4M For A Recording-Breaking August
Record Cannabis Sales in Michigan: Michigan's cannabis sales revenue reached $295.4 million in August, surpassing July's record of $276 million, with recreational sales making up the majority at over $294 million.
Industry Growth and Projections: The state's cannabis industry achieved $3.06 billion in sales for 2023, a 25% increase from the previous year, with projections suggesting total sales could exceed $3.32 billion in 2024.
Grown Rogue International's Expansion and Financial Outlook
- Revenue Growth Expectations: Grown Rogue International anticipates double-digit revenue growth in Q1 2026 compared to Q1 2025, indicating strong momentum in market recovery and boosting investor confidence.
- Production Capacity Expansion: The company plans to increase its flowering canopy from 37,000 square feet to 58,000 square feet in 2026, expecting a 50% boost in production capacity to meet demand in New Jersey, Illinois, and Minnesota, thereby solidifying its market position.
- Financial Support: Successfully secured a $12 million debt facility at a sub-8% interest rate, providing financial backing for expansion projects, particularly in Minnesota and New Jersey, which mitigates financial risk.
- Team Building and Management: By attracting external talent and promoting internal leaders, the company has strengthened its capabilities in key areas such as construction, marketing, and management, enhancing its ability to navigate market challenges and drive growth, reflecting its commitment to future development.
Grown Rogue International's Expansion Plans for 2026
- Revenue Growth Expectation: Grown Rogue International anticipates double-digit revenue growth in Q1 2026 compared to Q1 2025, indicating strong momentum in market recovery and boosting investor confidence.
- Production Capacity Increase: The company currently has a flowering canopy of 37,000 square feet, with plans to add 21,000 square feet in 2026, representing a 50% increase that will significantly enhance its market supply capabilities and support future sales growth.
- Debt Financing Support: Successfully secured a $12 million debt facility at a sub-8% interest rate, providing financial backing for expansion plans in New Jersey and Minnesota while reducing financial costs.
- Market Challenge Response: Despite facing cyclical pricing pressures in Oregon and Michigan, the company maintains a low-cost, high-quality production model, expecting double-digit revenue growth in Q1 2026, demonstrating its market adaptability and resilience.
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
Corporate Developments: The cannabis industry is experiencing significant activity with major acquisitions, such as Organigram's purchase of Collective Project Limited, and financial improvements reported by companies like Canopy Growth and Grown Rogue International, indicating a dynamic market landscape.
Regulatory and Product Innovations: Legal debates continue to shape cannabis policy, highlighted by a U.S. Supreme Court ruling favoring a trucker fired for THC use, while new product launches from brands like Grön and MariMed reflect ongoing consumer market expansion in states like Illinois.
Cannabis Co. Grown Rogue Reports 7% Increase In Q3 Revenue, Focuses On New Jersey And Illinois Expansion
Financial Performance: Grown Rogue International reported a 7% increase in revenue to $7 million for Q3 2024, but experienced a decrease in gross profit and operating cash flow due to increased expenses and pricing pressures. The net loss improved to $667,240 compared to the previous year.
Expansion Plans: The company is focusing on its expansions in New Jersey and Illinois, with product launches expected in December 2024 and ongoing construction aimed at increasing production capacity by mid-2025.
Grown Rogue Secures $800K, Vireo Forfeits 4.5M Warrants In Cannabis Shakeup—What's Next For Both?
Grown Rogue and Vireo Growth Agreement Termination: Grown Rogue International has terminated its advisory agreement with Vireo Growth, resulting in Vireo forfeiting 4.5 million warrants and agreeing to pay Grown Rogue $800,000, while Grown Rogue retains 10 million warrants.
Leadership Changes at Vireo Growth: Vireo Growth appointed Amber Shimpa as CEO following the resignation of Josh Rosen, who will remain an advisor, as the company prepares for expansion into Minnesota's adult-use market next year.
Cannabis Sales In Michigan Soar To $295.4M For A Recording-Breaking August
Record Cannabis Sales in Michigan: Michigan's cannabis sales revenue reached $295.4 million in August, surpassing July's record of $276 million, with recreational sales making up the majority at over $294 million.
Industry Growth and Projections: The state's cannabis industry achieved $3.06 billion in sales for 2023, a 25% increase from the previous year, with projections suggesting total sales could exceed $3.32 billion in 2024.
